Yes, I am "guilty" of responding to him.....but obviously I don't need to do that anymore as he is doing such a good job of responding to himself. Can't decide whether to laugh or feel sorry for the guy....I think I'll stick with laugh.
Say what??? All you have been doing is complaining about the stock price and then you start a topic labeled "This is a stock to avoid"....and now you say you are not upset with this stock? Do you hear yourself? OMG.
I mean really.....if you're so upset with this stock, why are you still holding???? You will do yourself and the rest of us a big favor by selling and moving on.
No, it is the other jerk, Jean Fonteneau,,,,,here is his tweet about it.....
Jean Fonteneau @JFinDallas · Dec 4
Really looking fwd to next SA piece after $AVXL release PR this Monday on how it's going to cure epilepsy in mice, another #AVXLArmy fun day
You are too shortsighted. What's more important is that they are moving forward with the pivotal trial AND using stem cells to treat chronic spinal injuries. Both of those milestones are huge and that is what investors should be focusing on.
Part of one of your posts today...."I did not insinuate that 4 and 5 most likely did not have any positive results. I explicitly stated it. I said why I thought that. I hold to that and think it is a legitimate and thoughtful and reasonable conclusion. It is almost 6 months out on 4 and 5."
Patient 4 was enrolled on August 20th and patient 5 on Sept. 8th. Your constant ranting and raving about no positive results on these 2 patients is annoying enough....especially since you DON'T know that as a fact...but saying they both are almost 6 months out is even worse.
Due to the primary endpoint of the new INSPIRE study being "proportion of patients that improve by at least 1 AIS grade at 6 months post-implant", we basically just need 2 more patients of the remaining 15 to surpass the 16% probable requirement of the FDA.
I agree mix that the bar is quite low. Actually, I think they only need TWO of the remaining 15 for AIS conversion. They already have 2 and 2 more would make it 4 out of 20 for a 20% conversion rate.